ArticleAsia-Pacific journal of oncology nursing2025
Translation and psychometric validation of the Persian Care Evaluation Scale-2 short version in bereaved family members of cancer patients.
Article in Asia-Pacific journal of oncology nursing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To translate and evaluate the psychometric validation of the Persian version of the Care Evaluation Scale-2.0 Short (CES2.0-S) for bereaved family members of cancer patients. Methods: This methodological study was conducted in Tehran in 2024. The scale was translated using forward-backward translation. Face validity was assessed through cognitive interviews with 10 bereaved family members, and content validity was evaluated by 10 palliative care experts using the Content Validity Index. Construct validity was examined through exploratory factor analysis and convergent validity. Reliability was assessed by internal consistency and test-retest stability over a two-week interval. Results: A total of 237 bereaved family members participated. Exploratory factor analysis identified two factors- support provided by the care team and access to healthcare services -explaining 63.4% of the total variance. The Persian CES2.0-S demonstrated strong internal consistency (Cronbach's α = 0.89) and test-retest reliability (ICC = 0.80). Convergent validity was supported by significant correlations with the Good Death Questionnaire-Short Form ( Conclusions: The Persian CES2.0-S is a valid and reliable instrument for assessing structures and processes of end-of-life care among bereaved family members of cancer patients. Its use may help identify areas requiring improvement and guide strategies to enhance the quality of end-of-life care, an essential goal of palliative care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.